US BANCORP \DE\ - APTEVO THERAPEUTICS INC ownership

APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L207. A total of 20 filers reported holding APTEVO THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of APTEVO THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$010.0%0.00%
Q2 2022$010.0%0.00%
Q1 2022$010.0%0.00%
Q4 2021$010.0%0.00%
Q3 2021$010.0%0.00%
Q2 2021$010.0%0.00%
Q1 2021$010.0%0.00%
Q4 2020$01
-91.7%
0.00%
Q3 2020$0120.0%0.00%
Q2 2020$012
-20.0%
0.00%
Q1 2020$0150.00%
Other shareholders
APTEVO THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 1,760,000$64,504,0009.85%
Stonepine Capital Management, LLC 18,280$670,0000.51%
Ghost Tree Capital, LLC 50,000$1,833,0000.41%
Anson Funds Management LP 45,462$1,666,0000.34%
RTW INVESTMENTS, LP 288,236$10,564,0000.18%
Dynamic Technology Lab Private Ltd 13,202$484,0000.08%
Alyeska Investment Group, L.P. 49,601$1,818,0000.03%
BOOTHBAY FUND MANAGEMENT, LLC 11,493$421,0000.02%
PURA VIDA INVESTMENTS, LLC 8,203$301,0000.01%
Renaissance Technologies 254,423$9,325,0000.01%
View complete list of APTEVO THERAPEUTICS INC shareholders